The Association between Wearing a Mask and COVID-19.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
30 08 2021
Historique:
received: 28 07 2021
revised: 19 08 2021
accepted: 19 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 15 9 2021
Statut: epublish

Résumé

With the widespread and increasing number of cases of Coronavirus Disease (2019) globally, countries have been taking preventive measures against this pandemic. However, there is no universal agreement across cultures on whether wearing face masks are an effective physical intervention against disease transmission. We investigated the relationship between mask wearing and COVID-19 among close contacts of COVID-19 patients in the Hiroshima Prefecture, Japan. In the Hiroshima Prefecture, a COVID-19 form adapted from the reporting form, "Japanese Surveillance in Post-Extreme Emergencies and Disasters", was developed to collect data from COVID-19 patients' close contacts under active epidemiological surveillance at Public Health Centers. The relative risk of COVID-19 for mask users versus non-mask users was calculated. A total of 820 interviewees were included in the analysis and 53.3% of them responded that they wore masks. Non-mask users were infected at a rate of 16.4%, while mask users were infected at a rate of 7.1%. Those who wore masks were infected at a rate of 0.4 times that of those who did not wear masks. (RR = 0.4, 95%CI = 0.3-0.6; Adjusted RR = 0.6, 95%CI = 0.3-0.9). These findings implied that COVID-19 could be avoided to a certain degree by wearing a mask.

Identifiants

pubmed: 34501719
pii: ijerph18179131
doi: 10.3390/ijerph18179131
pmc: PMC8431493
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Hiroshima Prefecture
ID : development of COVID-19 testing and research system through government-academia collaboration
Organisme : Ministry of Health, Labour and Welfare
ID : 20CA2063

Références

Biostatistics. 2005 Jan;6(1):39-44
pubmed: 15618526
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27285-27291
pubmed: 33060298
BMJ. 2020 Apr 9;369:m1435
pubmed: 32273267
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Epidemiology. 2009 Jul;20(4):488-95
pubmed: 19525685
Int J Nurs Stud. 2020 Aug;108:103629
pubmed: 32512240
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
BMC Public Health. 2020 Jun 16;20(1):948
pubmed: 32546228
PLoS One. 2020 Oct 15;15(10):e0240785
pubmed: 33057375
Lancet. 2020 Apr 11;395(10231):1190-1191
pubmed: 32240625
Emerg Infect Dis. 2020 Oct;26(10):
pubmed: 32639930
Tob Induc Dis. 2020 Mar 20;18:20
pubmed: 32206052
PLoS One. 2021 Feb 19;16(2):e0247313
pubmed: 33606830
Front Public Health. 2020 May 27;8:217
pubmed: 32574300
J Infect. 2020 Jul;81(1):107-114
pubmed: 32335167
Lancet Respir Med. 2020 May;8(5):434-436
pubmed: 32203710
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Ann Intern Med. 2021 Mar;174(3):335-343
pubmed: 33205991
J Autoimmun. 2012 May;38(2-3):J187-92
pubmed: 22178198
QJM. 2021 Jun 09;:
pubmed: 34109393
Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32293-32301
pubmed: 33273115
Infect Control Hosp Epidemiol. 2020 Jun;41(6):746-747
pubmed: 32192550
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116

Auteurs

Mana Sugimura (M)

Department of Public Health and Health Policy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.

Odgerel Chimed-Ochir (O)

Department of Public Health and Health Policy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.

Yui Yumiya (Y)

Department of Public Health and Health Policy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.

Hiroki Ohge (H)

Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima 734-8551, Japan.

Nobuaki Shime (N)

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.

Takemasa Sakaguchi (T)

Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.

Junko Tanaka (J)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.

Toshiro Takafuta (T)

Hiroshima City Funairi Citizens Hospital, Hiroshima 730-0844, Japan.

Michi Mimori (M)

Hiroshima City Health and Welfare Bureau, Hiroshima 730-8586, Japan.

Masao Kuwabara (M)

Hiroshima Prefectural Center for Disease Control and Prevention, Hiroshima 730-8511, Japan.

Toshimasa Asahara (T)

Hiroshima Prefectural Health and Welfare Bureau, Hiroshima 730-8511, Japan.

Eisaku Kishita (E)

Hiroshima Prefectural Health and Welfare Bureau, Hiroshima 730-8511, Japan.

Tatsuhiko Kubo (T)

Department of Public Health and Health Policy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH